A PROMIS fatigue short form for use by individuals who have multiple sclerosis

Karon F Cook1, Alyssa M Bamer, Toni S Roddey

  • 1Northwestern University, Chicago, IL, USA. karon.cook@northwestern.edu

Abstract

Insights

A new Patient Reported Outcomes Measurement Information System (PROMIS) fatigue short form for multiple sclerosis (MS) was developed. The PROMIS-Fatigue(MS) shows content validity and accurately measures fatigue in individuals with MS.

Area of Science:

  • Neurology
  • Psychometrics
  • Patient-Reported Outcomes

Background:

  • Fatigue is a significant and common symptom in multiple sclerosis (MS).
  • Existing measures may not fully capture the multifaceted nature of MS-related fatigue.
  • The Patient Reported Outcomes Measurement Information System (PROMIS) offers a robust item bank for developing patient-centered outcome measures.

Purpose of the Study:

  • To derive and validate a new short form measure of fatigue specifically for individuals with multiple sclerosis (MS).
  • To develop the PROMIS-Fatigue(MS) from the PROMIS fatigue item bank.

Main Methods:

  • A panel of clinicians and individuals with MS ranked the relevance of PROMIS fatigue items.
  • Eight highly relevant items were selected for the PROMIS-Fatigue(MS) based on relevance, content coverage, and discrimination.
  • The PROMIS-Fatigue(MS) and PROMIS-Fatigue(SFv1.0) were administered to 231 individuals with MS to assess validity.

Main Results:

  • Scores from the PROMIS-Fatigue(MS) and PROMIS-Fatigue(SFv1.0) were highly correlated (r = 0.92).
  • The PROMIS-Fatigue(MS) demonstrated discriminant validity and better targeted the content of participants' fatigue experiences.
  • No quantitative advantage was found for either short form in this analysis.

Conclusions:

  • The PROMIS-Fatigue(MS) is a valid measure for assessing fatigue in individuals with multiple sclerosis (MS).
  • The measure's items effectively discriminate between groups with differing fatigue levels.
  • The PROMIS-Fatigue(MS) is recommended for use in clinical and research settings to evaluate fatigue in MS.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Fatigue01:21

Fatigue

Fatigue occurs when materials rupture under repeated or fluctuating loads, even at stress levels far below their static breaking strength. It typically results in brittle failure, even for ductile materials. It is a critical consideration in designing machines and structural components subjected to repetitive or varying loads. The nature of these loadings can range from fluctuating loads like unbalanced pump impellers causing vibrations to repeatedly bending a thin steel rod wire back and forth...
Muscle Recovery and Fatigue01:24

Muscle Recovery and Fatigue

Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective response...
Narcolepsy01:07

Narcolepsy

Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...